Literature DB >> 175085

Corticotropic action of an intra-nasally applied synthetic ACTH derivative.

G Baumann, A Walser, P A Desaulles, F J Paesi, L Geller.   

Abstract

The corticotropic action of a synthetic ACTH derivative, D-Ser1 Lys17,18-1-18ACTH, after intranasal insufflation of 1 mg of the peptide was evaluated in 14 normal volunteers. Plasma cortisol and urinary 17-ketogenic steroids and 17-ketosteroids rose significantly over control values in all subjects (P less than 0.001). Plasma cortisol remained above the normal range for comparable clock times for 18 hr, but fell below 15 mug/100 ml after 12 hr. No evidence for suppression of the hypothalamo-pituitary axis was found the day after ACTH administration, as judged by normal plasma and urinary steroid values and normal diurnal variation. Intranasal administration of long-acting ACTH derivatives may provide a simple, painless and effective way to stimulate endogenous corticosteroid secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175085     DOI: 10.1210/jcem-42-1-60

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun

2.  Nasal absorption of insulin: enhancement by hydrophobic bile salts.

Authors:  G S Gordon; A C Moses; R D Silver; J S Flier; M C Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.